Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1982 Aug 1;156(2):634–639. doi: 10.1084/jem.156.2.634

Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates

PMCID: PMC2186768  PMID: 6980259

Abstract

The feasibility of selectively eliminating human antigen-specific B cell responses by treating cells in vitro with antigen covalently linked to a cell toxin was examined. Tetanus toxoid (TT) was conjugated to the toxin ricin via a thioether linkage. Peripheral blood mononuclear cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells were stimulated with pokeweed mitogen to induce antibody production. TT-specific antibody production was completely abrogated by preincubation with TT-ricin but not by TT alone or a mixture of TT and ricin. In contrast, polyclonal immunoglobulin production was not diminished by TT-ricin. This selective abrogation was also seen when B cells alone were preincubated with TT-ricin and a source of T cell help was later provided. T cell blastogenic responses to TT remained intact after TT-ricin exposure. Thus, antigen-toxin conjugates are capable of selectively eliminating specific antibody- producing B cell clones, while leaving intact the remainder of the B cell repertoire.

Full Text

The Full Text of this article is available as a PDF (434.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  2. Chang T. M., Neville D. M., Jr Artificial hybrid protein containing a toxic protein fragment and a cell membrane receptor-binding moiety in a disulfide conjugate. I. Synthesis of diphtheria toxin fragment A-S-S-human placental lactogen with methyl-5-bromovalerimidate. J Biol Chem. 1977 Feb 25;252(4):1505–1514. [PubMed] [Google Scholar]
  3. Fauci A. S. Immunoregulation in autoimmunity. J Allergy Clin Immunol. 1980 Jul;66(1):5–17. doi: 10.1016/0091-6749(80)90132-3. [DOI] [PubMed] [Google Scholar]
  4. Krolick K. A., Uhr J. W., Vitetta E. S. Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation. Nature. 1982 Feb 18;295(5850):604–605. doi: 10.1038/295604a0. [DOI] [PubMed] [Google Scholar]
  5. Krolick K. A., Villemez C., Isakson P., Uhr J. W., Vitetta E. S. Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5419–5423. doi: 10.1073/pnas.77.9.5419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lane H. C., Volkman D. J., Whalen G., Fauci A. S. In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements. J Exp Med. 1981 Oct 1;154(4):1043–1057. doi: 10.1084/jem.154.4.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Neville D. M., Jr, Youle R. J. Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy. Immunol Rev. 1982;62:75–91. doi: 10.1111/j.1600-065x.1982.tb00390.x. [DOI] [PubMed] [Google Scholar]
  8. Robbins A. R., Myerowitz R., Youle R. J., Murray G. J., Neville D. M., Jr The mannose 6-phosphate receptor of Chinese Hamster ovary cells. Isolation of mutants with altered receptors. J Biol Chem. 1981 Oct 25;256(20):10618–10622. [PubMed] [Google Scholar]
  9. Vallera D. A., Youle R. J., Neville D. M., Jr, Kersey J. H. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin. J Exp Med. 1982 Mar 1;155(3):949–954. doi: 10.1084/jem.155.3.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Volkman D. J., Lane H. C., Fauci A. S. Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2528–2531. doi: 10.1073/pnas.78.4.2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Youle R. J., Murray G. J., Neville D. M., Jr Studies on the galactose-binding site of ricin and the hybrid toxin Man6P-ricin. Cell. 1981 Feb;23(2):551–559. doi: 10.1016/0092-8674(81)90151-3. [DOI] [PubMed] [Google Scholar]
  12. Youle R. J., Neville D. M., Jr Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5483–5486. doi: 10.1073/pnas.77.9.5483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Youle R. J., Neville D. M., Jr Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution. J Biol Chem. 1982 Feb 25;257(4):1598–1601. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES